Influenza vaccine effectiveness among children 6 to 59 months of age during 2 influenza seasons: A case-cohort study

Archives of Pediatrics and Adolescent Medicine

Volumn 162, Issue 10, 2008, Pages 943-951

  Szilagyi, Peter G ^a,f   Fairbrother, Gerry ^b   Griffin, Marie R ^c   Hornung, Richard W ^b   Donauer, Stephanie ^b   Morrow, Ardythe ^b   Altaye, Mekibib ^b   Zhu, Yuwei ^c   Ambrose, Sandra ^a   Edwards, Kathryn M ^c   Poehling, Katherine A ^d   Lofthus, Geraldine ^a   Holloway, Michol ^c   Finelli, Lyn ^e   Iwane, Marika ^e   Staat, Mary Allen ^b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d WAKE FOREST BAPTIST HEALTH   (United States)

^e CENTERS FOR DIS CONTR AND PREV   (United States)

^f STRONG MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; EMERGENCY WARD; FEMALE; HUMAN; INFANT; INFLUENZA; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRESCHOOL CHILD; PRIORITY JOURNAL; VACCINATION;

AGE DISTRIBUTION; AMBULATORY CARE; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; CLUSTER ANALYSIS; COHORT STUDIES; COMMUNICABLE DISEASE CONTROL; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; IMMUNIZATION SCHEDULE; INCIDENCE; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; OFFICE VISITS; RISK ASSESSMENT; SEASONS; SENSITIVITY AND SPECIFICITY; SEX DISTRIBUTION; TOTAL QUALITY MANAGEMENT; VACCINATION; VACCINES, INACTIVATED;

EID: 43249110873     PISSN: 10724710     EISSN: 15383628     Source Type: Journal    
DOI: 10.1001/archpedi.162.10.943     Document Type: Article

References (49)

1. Perrotta DM, Decker M, Glezen WP. Acute respiratory disease hospitalizations as a measure of impact of epidemic influenza. Am J Epidemiol. 1985;122(3):468-476.
2. Neuzil KM, Mellen BG, Wright PF, Mitchel EF Jr, Griffin MR. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med. 2000;342(4):225-231.
3. Izurieta HS, Thompson WW, Kramarz P, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med. 2000;342(4):232-239.
4. O'Brien MA, Uyeki TM, Shay D, et al. Incidence of outpatient visits and hospitalizations related to influenza in infants and young children. Pediatrics. 2004;113(3, pt 1):585-593.
5. Iwane MK, Edwards KM, Szilagyi PG, et al. Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics. 2004;113(6):1758-1764.
6. Poehling KA, Edwards KM, Iwane MK, et al. The under-recognized burden of influenza illness in young children. N Engl J Med. 2006;355(1):31-40.
7. Harper SA, Fukuda K, Uyeki TM, Cox NJ, Bridges CB; Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP). Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP) [published correction appears in MMWR Recomm Rep. 2004;53(32):743]. MMWR Recomm Rep. 2004;53(RR-6):1-40.
8. Advisory Committee on Immunization Practices; Smith NM, Bresee JS, Shay DK, Uyeki TM, Cox NJ, Strikas RA. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP) [published correction appears in MMWR Morb Mortal Wkly Rep. 2006;55(29):800]. MMWR Recomm Rep. 2006;55(RR-10):1-42.
9. Boyer KM, Cherry JD, Wright PF, et al. Clinical reactions and serologic responses in healthy children aged six to 35 months after two-dose regimens of inactivated A/New Jersey/76 influenza virus vaccines. J Infect Dis. 1977;136(suppl):S579-S583.
10. Gonzalez M, Pirez MC, Ward E, Dibarboure H, Garcia A, Picolet H. Safety and immunogenicity of a paediatric presentation of an influenza vaccine. Arch Dis Child. 2000;83(6):488-491.
11. Hoberman A, Greenberg DP, Paradise JL, et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial. JAMA. 2003;290(12):1608-1616.
12. Englund JA, Walter EB, Fairchok MP, Monto AS, Neuzil KM. A comparison of 2 influenza vaccine schedules in 6- to 23-month-old children. Pediatrics. 2005;115(4):1039-1047.
13. Zangwill KM, Belshe RB. Safety and efficacy of trivalent inactivated influenza vaccine in young children: a summary for the new era of routine vaccination. Pediatr Infect Dis J. 2004;23(3):189-197.
14. Jefferson T, Smith S, Demicheli V, Harnden A, Rivetti A, Di Pietrantonj C. Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: systematic review. Lancet. 2005;365(9461):773-780.
15. Kramarz P, DeStefano F, Gargiullo PM, et al. Influenza vaccination in children with asthma in health maintenance organizations: Vaccine Safety Datalink Team. Vaccine. 2000;18(21):2288-2294.
16. Chung EK, Casey R, Pinto-Martin JA, Pawlowski NA, Bell LM. Routine and influenza vaccination rates in children with asthma. Ann Allergy Asthma Immunol. 1998;80(4):318-322.
17. Kawai N, Ikematsu H, Iwaki N, et al. A prospective, Internet-based study of the effectiveness and safety of influenza vaccination in the 2001-2002 influenza season. Vaccine. 2003;21(31):4507-4513.
18. Ritzwoller DP, Bridges CB, Shetterly S, Yamasaki K, Kolczak M, France EK. Effectiveness of the 2003-2004 influenza vaccine among children 6 months to 8 years of age, with 1 vs 2 doses. Pediatrics. 2005;116(1):153-159.
19. Halloran ME, Longini IM Jr, Gaglani MJ, et al. Estimating efficacy of trivalent, cold-adapted, influenza virus vaccine (CAIV-T) against influenza A (H1N1) and B using surveillance cultures. Am J Epidemiol. 2003;158(4):305-311.
20. Allison MA, Daley MF, Crane LA, et al. Influenza vaccine effectiveness in healthy 6- to 21-month-old children during the 2003-2004 season. J Pediatr. 2006;149(6):755-762.
21. Shuler CM, Iwamoto M, Bridges CB, et al. Vaccine effectiveness against medically attended, laboratory-confirmed influenza among children aged 6 to 59 months, 2003-2004. Pediatrics. 2007;119(3):e587-e595. http://pediatrics.aappublications.org/cgi/content/full/119/3/e587.
22. New Vaccine Surveillance Network. Centers for Disease Control and Prevention Web site. http://www.cdc.gov/vaccines/stats-surv/nvsn/default.htm. Accessed December 11, 2007.
23. Szilagyi PG, Iwane MK, Schaffer S, et al. Potential burden of universal influenza vaccination of young children on visits to primary care practices. Pediatrics. 2003;112(4):821-828.
24. Szilagyi PG, Iwane MK, Humiston SG, et al. Time spent by primary care practices on pediatric influenza vaccination visits: implications for universal influenza vaccination. Arch Pediatr Adolesc Med. 2003;157(2):191-195.
25. Poehling KA, Szilagyi PG, Edwards K, et al. Streptococcus pneumoniae-related illnesses in young children: secular trends and regional variation. Pediatr Infect Dis J. 2003;22(5):413-418.
26. Poehling KA, Lafleur BJ, Szilagyi PG, et al. Population-based impact of pneumococcal conjugate vaccine in young children. Pediatrics. 2004;114(3):755-761.
27. Humiston SG, Szilagyi PG, Iwane MK, et al. The feasibility of universal influenza vaccination for infants and toddlers. Arch Pediatr Adolesc Med. 2004;158(9):867-874.
28. Barlow WE, Ichikawa L, Rosner D, Izumi S. Analysis of case-cohort designs. J Clin Epidemiol. 1999;52(12):1165-1172.
29. Borgan O, Langholz B, Samuelsen SO, Goldstein L, Pogoda J. Exposure stratified case-cohort designs. Lifetime Data Anal. 2000;6(1):39-58.
30. Moulton LH, Chung S, Croll J, Reid R, Weatherholz RC, Santosham M. Estimation of the indirect effect of Haemophilus influenzae type B conjugate vaccine in an American Indian population. Int J Epidemiol. 2000;29(4):753-756.
31. Iyer SB, Gerber MA, Pomerantz WJ, Mortensen JE, Ruddy RM. Effect of point-of-care influenza testing on management of febrile children [published online November 1, 2006]. Acad Emerg Med. 2006;13(12):1259-1268.
32. Weinberg GA, Erdman DD, Edwards KM, et al. Superiority of reverse-transcription polymerase chain reaction to conventional viral culture in the diagnosis of acute respiratory tract infections in children. J Infect Dis. 2004;189(4):706-710.
33. Szilagyi PG, Schaffer S, Shone L, et al. Reducing geographic, racial, and ethnic disparities in childhood immunization rates by using reminder/recall interventions in urban primary care practices. Pediatrics. 2002;110(5):e58. http://pediatrics.aappublications.org/cgi/content/full/110/5/ e58.
34. Szilagyi PG, Griffin MR, Shone LP, et al. New Vaccine Surveillance Network: the impact of conjugate pneumococcal vaccination on routine childhood vaccination and primary care use in 2 counties. Pediatrics. 2006;118(4):1394-1402.
35. American Academy of Pediatrics. Influenza. In: Pickering LK, ed. Red Book: Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics; 2003:388.
36. Prentice RL. A case-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika. 1986;73(1):1-11.
37. Binder DA. Fitting Cox's proportional hazards models from survey data. Biometrika Trust. 1992;79:139-147.
38. Lu SE, Shih JH. Case-cohort designs and analysis for clustered failure time data. Biometrics. 2006;62(4):1138-1148.
39. Centers for Disease Control and Prevention (CDC). Update: influenza activity - United States and worldwide, 2003-04 season, and composition of the 2004-05 influenza vaccine. MMWR Morb Mortal Wkly Rep. 2004;53(25):547-552.
40. Centers for Disease Control and Prevention (CDC). Update: influenza activity - United States and worldwide, 2004-05 season. MMWR Morb Mortal Wkly Rep. 2005;54(25):631-634.
41. Ohmit SE, Victor JC, Rotthoff JR, et al. Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. N Engl J Med. 2006;355(24):2513-2522.
42. Centers for Disease Control and Prevention. Pneumonia and influenza mortality for 122 US cities: week ending 1/22/07. http://www.cdc.gov/flu/weekly/ weeklyarchives2007-2008/bigpi45.htm. Accessed January 30, 2008.
43. Jackson LA, Jackson ML, Nelson JC, Neuzil KM, Weiss NS. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol. 2006;35(2):337-344.
44. Eisenberg EW, Szilagyi PG, Fairbrother G, et al. Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003-2004 and 2004-2005 influenza seasons. Pediatrics. In press.
45. Belshe RB, Edwards KM, Vesikari T, et al; CAIV-T Comparative Efficacy Study Group. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med. 2007;356(7):685-696.
46. Cox NJ, Bridges CB. Inactivated and live attenuated influenza vaccines in young children-how do they compare? N Engl J Med. 2007;356(7):729-731.
47. Piedra PA, Gaglani M, Kozinetz C, et al. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children. Pediatrics. 2007;120(3):e553-e564. http://pediatrics.aapublications.org/ cgi/content/full/120/3/e553.
48. Chevarley FM, Owens PL, Zodet MW, Simpson LA, McCormick MC, Dougherty D. Health care for children and youth in the United States: annual report on patterns of coverage, utilization, quality, and expenditures by a county level of urban influence. Ambul Pediatr. 2006;6(5):241-264.
49. Owens PL, Zodet MW, Berdahl T, Dougherty D, McCormick MC, Simpson LA. Annual report on health care for children and youth in the United States: focus on injury-related emergency department utilization and expenditures. Ambul Pediatr. 2008;8(4):219-240.e17.